{"id":852816,"date":"2025-05-20T09:05:48","date_gmt":"2025-05-20T13:05:48","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/clearmind-medicine-to-host-live-webinar-gazing-through-the-crystal-ball-featuring-leading-psychedelic-experts-2\/"},"modified":"2025-05-20T09:05:48","modified_gmt":"2025-05-20T13:05:48","slug":"clearmind-medicine-to-host-live-webinar-gazing-through-the-crystal-ball-featuring-leading-psychedelic-experts-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/clearmind-medicine-to-host-live-webinar-gazing-through-the-crystal-ball-featuring-leading-psychedelic-experts-2\/","title":{"rendered":"Clearmind Medicine to Host Live Webinar \u201cGazing Through the Crystal Ball\u201d Featuring Leading Psychedelic Experts"},"content":{"rendered":"<div class=\"mw_release\">\n<p>Vancouver, Canada, May  20, 2025  (GLOBE NEWSWIRE) &#8212; Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (\u201cClearmind\u201d or the &#8220;Company&#8221;), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, is pleased to announce its upcoming live webinar titled &#8220;Gazing Through the Crystal Ball.&#8221; The event is scheduled for May 21, 2025, at 12:00 PM ET (9:00 AM PT) and will feature a distinguished panel of experts discussing the evolving landscape of psychedelic science and business in the context of changing FDA policies and political climates.<\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=stcmZ7MA5VrBcs2u9uQbLMCDsjExAfcjfrXbSsC2BeRX8Yk9ZZHs11Hv544VPIaFoLW1VrnrWF-3pRMYiZjVqsp2mrNtiMyc1O3bCU7wIxuQzylHZc7mBClj2at_U9ZdngvFJLq7-U3P2SKd8sor1tWtLNPGk-luPbgMvy4uVsU=\" rel=\"nofollow\" target=\"_blank\">Register here<\/a>\n      <\/p>\n<p>For more information: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DMWLGAdPF-u52OZKLHoS-8lKD8dKFV-8qaBii0RGfwGnZgAT9pt6yhvQgbJfU293JqwiWYrKv2gBDcu7XTBzeHWp6NblbVgUPYhZ5enV9n7-i2DgFhdlhRc0IYjxrCs_txpD2azZaFjrXuiOYq4k_rOTg9RStSWkxb6tBRcK6MFDYXwvCNONWWoHg9OlVzPW0V6eigWe5VlnODuiggHy-VIVALLZ8Fz04e9cmv-h5grzqYWjKZwt_4PFZ-zP6rnz\" rel=\"nofollow\" target=\"_blank\">https:\/\/www.clearmindmedicine.com\/upcoming-events\/gazing-through-the-crystal-ball<\/a><\/p>\n<p>\n        <strong>Featured Speakers Include:<\/strong>\n      <\/p>\n<p>\n        <strong>Rick Doblin, PhD<\/strong> \u2013 Founder and President of the Multidisciplinary Association for Psychedelic Studies (MAPS). His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist.<\/p>\n<p>\n        <strong>Robin Carhart-Harris, PhD<\/strong> \u2013 Robin Carhart-Harris, PhD, is an esteemed neuropharmacologist, psychologist, and became the Ralph Metzner Distinguished Professor in Neurology and Psychiatry at the University of California, San Francisco in 2021. His current research program is focused on the mechanisms of action of psychedelics and psychedelic-therapy.<\/p>\n<p>\n        <strong>Dr. Adi Zuloff-Shani<\/strong> \u2013 Chief Executive Officer of Clearmind Medicine. Dr. Zuloff-Shani brings decades of scientific, clinical and regulatory expertise and currently leads the development of Clearmind\u2019s innovative treatment for Alcohol Use Disorder (AUD), CMND-100, which recently advanced into FDA-approved clinical trials.<\/p>\n<p>\n        <strong>Mark Haden<\/strong> \u2013 VP Business Development of Clearmind. Adjunct Professor at the University of British Columbia School of Population and Public Health and former Executive Director of MAPS Canada. Mr. Haden is a leading voice in drug policy reform and has worked extensively on public health-based approaches to psychedelic regulation and integration.<\/p>\n<p>The panel discussion will be moderated by <strong>Shannon Smadella<\/strong>, an award-winning social entrepreneur and business strategist with deep experience in psychedelic advocacy and organizational leadership. She is a former board member of MAPS Canada, spokesperson and operations director of World Psychedelics Day, and co-director of the International Psychedelics Awareness Foundation.<\/p>\n<p>\u201cWe\u2019re in a rare moment where decades of clinical insight, policy reform, and scientific progress are converging with a vibrant psychedelic industry,\u201d says Mark Haden, Founder of MAPS Canada, and VP at Clearmind Medicine. \u201cAs legislation evolves, the future of this field will be shaped by how we align evidence, ethics, and innovation. This webinar will explore not only the policy and research landscape, but also the emerging opportunities in a sector that is adapting, maturing, and far from slowing down.\u201d<\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=stcmZ7MA5VrBcs2u9uQbLLcw23ra9DbSd6IdLOppjQrVJoDOVOuBBkzizkMGxx4fJeY28UA0YbUkDsVQG6uFsLaGWbuS86dD9t2cz86nrmtOl2d9cRepQ5U43xB4x59W86wg14TvGnKSnEJ89SsrjjoPydxV7P-SeCl8CuEm4fI=\" rel=\"nofollow\" target=\"_blank\">Register here<\/a>\n      <\/p>\n<p>For additional information or media inquiries, please contact Clearmind at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wfYv2_2Ybz5HWSt0oBTSbSfXxg2dl4DmYSL9o-QJzz-6VQZZKOV02SfSrSa80nnUQqCryZ2XXNqHaedeucc9C-PYRkxqyK7zH_0Q2JlUnmyrbmY1kt4UPZguw8ofaRuH\" rel=\"nofollow\" target=\"_blank\">invest@clearmindmedicine.com<\/a>.<\/p>\n<p>\n        <strong>About\u00a0Clearmind\u00a0Medicine Inc.<\/strong>\n      <\/p>\n<p>Clearmind is a clinical-stage psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods or supplements.<\/p>\n<p>The Company\u2019s intellectual portfolio currently consists of nineteen patent families including 31 granted patents. The Company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.<\/p>\n<p>Shares of Clearmind are listed for trading on Nasdaq under the symbol &#8220;CMND&#8221; and the Frankfurt Stock Exchange under the symbol \u201cCWY0.\u201d<\/p>\n<p>For further information visit:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DMWLGAdPF-u52OZKLHoS-8lKD8dKFV-8qaBii0RGfwElFTiT8eOoF8Q8ioKXXpZBlubyVFX4oguvPMQivKkfMVrs_5hwvauLdGKyhZeNpSSNz2XboC4IBZkCG9CgkulN\" rel=\"nofollow\" target=\"_blank\">https:\/\/www.clearmindmedicine.com<\/a>\u00a0or contact:<\/p>\n<p>Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wfYv2_2Ybz5HWSt0oBTSbSfXxg2dl4DmYSL9o-QJzz-mFu044pQ7Ak7o4PVcHDI7CviA5CP7IBHEZJbU7VU6Xw1k4yWn6DNYXFz1dgzPRGQLysZkGFByryT7Eoy1ASwb\" rel=\"nofollow\" target=\"_blank\">invest@clearmindmedicine.com<\/a><\/p>\n<p>Telephone: (604) 260-1566<br \/>US:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Uy26tfKFD1bf8hed2iNpWN-SvlmTWS-adw0lKNd_L-lktJJQdOpf_Bo1gsSS5wqy0A8YwG3PfRGhgRgKaNxPbEenm3elKyUJiD6u9qzT_iE=\" rel=\"nofollow\" target=\"_blank\">CMND@crescendo-ir.com<\/a><\/p>\n<p>General Inquiries<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nULlRz6RjuIF1KJmLMjmVhdeCjCIvwu6NUPPEM9Qwjbb8vW4uSK4HTz5DUdHCFvuaCxh34Ph_Pewl6e5STwrz4u8hxP-D5jyP8yXvBsF9JpzvYcPRUqzrzQl3DLnbXcZ\" rel=\"nofollow\" target=\"_blank\">Info@Clearmindmedicine.com<\/a><br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9EDut4GcW99eBSRwMiZJZ0zk5R6XPqVAeShO-ir_ae3k5VTtkULi_w6wOd5Bg7MAe_q25QtZdBsybSJqSw18QzcJlJ9L2vpbTueRhBx1YENde1WZi_J-Zb3GvP_Ta-0w\" rel=\"nofollow\" target=\"_blank\">www.Clearmindmedicine.com<\/a><\/p>\n<p>\n        <strong>Forward-Looking Statements:<\/strong>\n      <\/p>\n<p>\n        <em>This press release contains \u201cforward-looking statements\u201d within the meaning of the Private Securities Litigation Reform Act and other securities laws. Words such as \u201cexpects,\u201d \u201canticipates,\u201d \u201cintends,\u201d \u201cplans,\u201d \u201cbelieves,\u201d \u201cseeks,\u201d \u201cestimates\u201d and similar expressions or variations of such words are intended to identify forward-looking statements. For example, the Company is using forward-looking statements when it discusses the future of the psychedelic industry and the evolution of legislation with respect to the psychedelic industry<\/em>.<em> Forward-looking statements are not historical facts, and are based upon management\u2019s current expectations, beliefs and projections, many of which, by their nature, are inherently uncertain. Such expectations, beliefs and projections are expressed in good faith.\u00a0However, there can be no assurance that management\u2019s expectations, beliefs and projections will be achieved, and actual results may differ materially from what is expressed in or indicated by the forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the forward-looking statements. For a more detailed description of the risks and uncertainties affecting the Company, reference is\u00a0made to the Company\u2019s reports filed from time to time with the Securities and Exchange Commission (\u201cSEC\u201d), including, but not limited to, the risks detailed in the Company\u2019s annual report on Form 20-F for the fiscal year ended October 31,\u00a02024\u00a0and subsequent filings with the SEC. Forward-looking statements speak only as of the date the statements are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events or circumstances, changes in assumptions or changes in other factors affecting forward-looking information except to the extent required by applicable securities laws. If the Company does update one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect thereto or with respect to other forward-looking statements. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Clearmind is not responsible for the contents of third-party websites.<\/em><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ1NDkxNSM2OTUxNTU2IzUwMDA4NjkzNA==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZDY0YTBhZmItNTYwNy00NzE2LTk5YzctYTE5MjQxY2ZkODBhLTUwMDA4NjkzNC0yMDI1LTA1LTIwLWVu\/tiny\/Clearmind-Medicine-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Vancouver, Canada, May 20, 2025 (GLOBE NEWSWIRE) &#8212; Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (\u201cClearmind\u201d or the &#8220;Company&#8221;), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, is pleased to announce its upcoming live webinar titled &#8220;Gazing Through the Crystal Ball.&#8221; The event is scheduled for May 21, 2025, at 12:00 PM ET (9:00 AM PT) and will feature a distinguished panel of experts discussing the evolving landscape of psychedelic science and business in the context of changing FDA policies and political climates. Register here For more information: https:\/\/www.clearmindmedicine.com\/upcoming-events\/gazing-through-the-crystal-ball Featured Speakers Include: Rick Doblin, PhD \u2013 Founder and President of the Multidisciplinary Association for Psychedelic Studies (MAPS). His professional &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/clearmind-medicine-to-host-live-webinar-gazing-through-the-crystal-ball-featuring-leading-psychedelic-experts-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Clearmind Medicine to Host Live Webinar \u201cGazing Through the Crystal Ball\u201d Featuring Leading Psychedelic Experts&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-852816","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Clearmind Medicine to Host Live Webinar \u201cGazing Through the Crystal Ball\u201d Featuring Leading Psychedelic Experts - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/clearmind-medicine-to-host-live-webinar-gazing-through-the-crystal-ball-featuring-leading-psychedelic-experts-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clearmind Medicine to Host Live Webinar \u201cGazing Through the Crystal Ball\u201d Featuring Leading Psychedelic Experts - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Vancouver, Canada, May 20, 2025 (GLOBE NEWSWIRE) &#8212; Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (\u201cClearmind\u201d or the &#8220;Company&#8221;), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, is pleased to announce its upcoming live webinar titled &#8220;Gazing Through the Crystal Ball.&#8221; The event is scheduled for May 21, 2025, at 12:00 PM ET (9:00 AM PT) and will feature a distinguished panel of experts discussing the evolving landscape of psychedelic science and business in the context of changing FDA policies and political climates. Register here For more information: https:\/\/www.clearmindmedicine.com\/upcoming-events\/gazing-through-the-crystal-ball Featured Speakers Include: Rick Doblin, PhD \u2013 Founder and President of the Multidisciplinary Association for Psychedelic Studies (MAPS). His professional &hellip; Continue reading &quot;Clearmind Medicine to Host Live Webinar \u201cGazing Through the Crystal Ball\u201d Featuring Leading Psychedelic Experts&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/clearmind-medicine-to-host-live-webinar-gazing-through-the-crystal-ball-featuring-leading-psychedelic-experts-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-20T13:05:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ1NDkxNSM2OTUxNTU2IzUwMDA4NjkzNA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearmind-medicine-to-host-live-webinar-gazing-through-the-crystal-ball-featuring-leading-psychedelic-experts-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearmind-medicine-to-host-live-webinar-gazing-through-the-crystal-ball-featuring-leading-psychedelic-experts-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Clearmind Medicine to Host Live Webinar \u201cGazing Through the Crystal Ball\u201d Featuring Leading Psychedelic Experts\",\"datePublished\":\"2025-05-20T13:05:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearmind-medicine-to-host-live-webinar-gazing-through-the-crystal-ball-featuring-leading-psychedelic-experts-2\\\/\"},\"wordCount\":949,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearmind-medicine-to-host-live-webinar-gazing-through-the-crystal-ball-featuring-leading-psychedelic-experts-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ1NDkxNSM2OTUxNTU2IzUwMDA4NjkzNA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearmind-medicine-to-host-live-webinar-gazing-through-the-crystal-ball-featuring-leading-psychedelic-experts-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearmind-medicine-to-host-live-webinar-gazing-through-the-crystal-ball-featuring-leading-psychedelic-experts-2\\\/\",\"name\":\"Clearmind Medicine to Host Live Webinar \u201cGazing Through the Crystal Ball\u201d Featuring Leading Psychedelic Experts - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearmind-medicine-to-host-live-webinar-gazing-through-the-crystal-ball-featuring-leading-psychedelic-experts-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearmind-medicine-to-host-live-webinar-gazing-through-the-crystal-ball-featuring-leading-psychedelic-experts-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ1NDkxNSM2OTUxNTU2IzUwMDA4NjkzNA==\",\"datePublished\":\"2025-05-20T13:05:48+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearmind-medicine-to-host-live-webinar-gazing-through-the-crystal-ball-featuring-leading-psychedelic-experts-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearmind-medicine-to-host-live-webinar-gazing-through-the-crystal-ball-featuring-leading-psychedelic-experts-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearmind-medicine-to-host-live-webinar-gazing-through-the-crystal-ball-featuring-leading-psychedelic-experts-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ1NDkxNSM2OTUxNTU2IzUwMDA4NjkzNA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ1NDkxNSM2OTUxNTU2IzUwMDA4NjkzNA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearmind-medicine-to-host-live-webinar-gazing-through-the-crystal-ball-featuring-leading-psychedelic-experts-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Clearmind Medicine to Host Live Webinar \u201cGazing Through the Crystal Ball\u201d Featuring Leading Psychedelic Experts\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Clearmind Medicine to Host Live Webinar \u201cGazing Through the Crystal Ball\u201d Featuring Leading Psychedelic Experts - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/clearmind-medicine-to-host-live-webinar-gazing-through-the-crystal-ball-featuring-leading-psychedelic-experts-2\/","og_locale":"en_US","og_type":"article","og_title":"Clearmind Medicine to Host Live Webinar \u201cGazing Through the Crystal Ball\u201d Featuring Leading Psychedelic Experts - Market Newsdesk","og_description":"Vancouver, Canada, May 20, 2025 (GLOBE NEWSWIRE) &#8212; Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (\u201cClearmind\u201d or the &#8220;Company&#8221;), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, is pleased to announce its upcoming live webinar titled &#8220;Gazing Through the Crystal Ball.&#8221; The event is scheduled for May 21, 2025, at 12:00 PM ET (9:00 AM PT) and will feature a distinguished panel of experts discussing the evolving landscape of psychedelic science and business in the context of changing FDA policies and political climates. Register here For more information: https:\/\/www.clearmindmedicine.com\/upcoming-events\/gazing-through-the-crystal-ball Featured Speakers Include: Rick Doblin, PhD \u2013 Founder and President of the Multidisciplinary Association for Psychedelic Studies (MAPS). His professional &hellip; Continue reading \"Clearmind Medicine to Host Live Webinar \u201cGazing Through the Crystal Ball\u201d Featuring Leading Psychedelic Experts\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/clearmind-medicine-to-host-live-webinar-gazing-through-the-crystal-ball-featuring-leading-psychedelic-experts-2\/","og_site_name":"Market Newsdesk","article_published_time":"2025-05-20T13:05:48+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ1NDkxNSM2OTUxNTU2IzUwMDA4NjkzNA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearmind-medicine-to-host-live-webinar-gazing-through-the-crystal-ball-featuring-leading-psychedelic-experts-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearmind-medicine-to-host-live-webinar-gazing-through-the-crystal-ball-featuring-leading-psychedelic-experts-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Clearmind Medicine to Host Live Webinar \u201cGazing Through the Crystal Ball\u201d Featuring Leading Psychedelic Experts","datePublished":"2025-05-20T13:05:48+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearmind-medicine-to-host-live-webinar-gazing-through-the-crystal-ball-featuring-leading-psychedelic-experts-2\/"},"wordCount":949,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearmind-medicine-to-host-live-webinar-gazing-through-the-crystal-ball-featuring-leading-psychedelic-experts-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ1NDkxNSM2OTUxNTU2IzUwMDA4NjkzNA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearmind-medicine-to-host-live-webinar-gazing-through-the-crystal-ball-featuring-leading-psychedelic-experts-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/clearmind-medicine-to-host-live-webinar-gazing-through-the-crystal-ball-featuring-leading-psychedelic-experts-2\/","name":"Clearmind Medicine to Host Live Webinar \u201cGazing Through the Crystal Ball\u201d Featuring Leading Psychedelic Experts - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearmind-medicine-to-host-live-webinar-gazing-through-the-crystal-ball-featuring-leading-psychedelic-experts-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearmind-medicine-to-host-live-webinar-gazing-through-the-crystal-ball-featuring-leading-psychedelic-experts-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ1NDkxNSM2OTUxNTU2IzUwMDA4NjkzNA==","datePublished":"2025-05-20T13:05:48+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearmind-medicine-to-host-live-webinar-gazing-through-the-crystal-ball-featuring-leading-psychedelic-experts-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/clearmind-medicine-to-host-live-webinar-gazing-through-the-crystal-ball-featuring-leading-psychedelic-experts-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearmind-medicine-to-host-live-webinar-gazing-through-the-crystal-ball-featuring-leading-psychedelic-experts-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ1NDkxNSM2OTUxNTU2IzUwMDA4NjkzNA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ1NDkxNSM2OTUxNTU2IzUwMDA4NjkzNA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearmind-medicine-to-host-live-webinar-gazing-through-the-crystal-ball-featuring-leading-psychedelic-experts-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Clearmind Medicine to Host Live Webinar \u201cGazing Through the Crystal Ball\u201d Featuring Leading Psychedelic Experts"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/852816","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=852816"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/852816\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=852816"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=852816"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=852816"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}